Please login to the form below

Not currently logged in
Email:
Password:

New UK cell therapy centre

The UK Technology Strategy Board is calling for expressions of interest in a new technology and innovation centre for cell therapy

The UK's Technology Strategy Board is calling for expressions of interest (EOI) in a new technology and innovation centre for cell therapy from organisations that may want to lead or form part of the centre.

The centre will be based in the UK and support the development and commercialisation of cell therapies and advanced therapeutics, as well as the underpinning technologies for manufacturing, quality control, safety and efficacy challenges for these new treatments. The ultimate goal is to enable more effective commercialisation of this new technology and wealth generation for the UK.

It will be the second technology and innovation centre to be established as part of the UK government's £200m programme to set up a network of centres over the next four years.

The Technology Strategy Board believes these technology and innovation centres will be drivers of future economic growth, attracting substantial investment to establish world-leading capability and global impact, in pre-commercial development. They will provide access for business to the best technical expertise, infrastructure, skills and equipment, which individual companies cannot afford to invest in on their own.

They are likely to be funded on the basis of one-third core funding from the Technology Strategy Board, one-third from competitively won collaborative R&D grants co-funded by business and one-third from business contracts.

The new centre will complement and draw on other programmes of national investment delivered by the Technology Strategy Board as well as linking into and accessing EU programmes.

Register interest and download the EOI form. Alternatively, organisations wishing to work with the new centre once it is established should email: centres@tsb.gov.uk. The deadline to register for EOI forms is June 9, 2011. Forms must be submitted by June 16, 2011. The deadline for receipt of full applications is September 2, 2011.

11th May 2011

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
IGNIFI

We’re IGNIFI. An independent creative agency, we help spark and sustain successful brands for some of the biggest names in...

Latest intelligence

Are you ready for the digital health revolution?
In this edition of Delta magazine, we explore how rapid digitalization has transformed the care pathway and reveal how life science companies can succeed in the digital age....
#DemandDiversity: Can new medical publication guidelines help fix diversity in clinical trials?
Over the last 8 months, JAMA have been working on a new set of guidelines for research papers looking to publish with them, which is summarised in their latest editorial...
DATA shutterstock_1818502577-640.jpg
Empowering patients empowers results
Patient-centricity is key when it comes to creating a more flexible, efficient and modern process for clinical trials...

Infographics